Arias-Lorza, Andrés M.
Costello, James R.
Hingorani, Sunil R.
Von Hoff, Daniel D.
Korn, Ronald L.
Raghunand, Natarajan
Funding for this research was provided by:
National Institutes of Health (P30 CA076292)
Article History
Received: 31 August 2023
Accepted: 17 May 2024
First Online: 21 May 2024
Competing interests
: NR received a research grant from Halozyme Therapeutics for the work reported here. SRH and DDVH received funding to their institutions from Halozyme to defray study-related costs. RLK is Founder and CEO of Imaging Endpoints, LLC. No potential conflicts of interest were disclosed by the other authors. The data analyses reported here remained under the full control of the authors.